Israel Rapid Influenza Diagnostic Test Market Outlook

in recent years, there has been an increase in demand for rapid influenza diagnostic tests in israel due to the increasing prevalence of influenza among the population. according to the ministry of health in israel, there were nearly 80,000 cases of influenza in 2016. the increasing demand for rapid diagnosis of influenza has been driven by the need to identify and treat the disease quickly to improve patient outcomes and reduce further transmission. rapid influenza diagnostic tests are quick and accurate techniques that are used to diagnose influenza in a single visit. the test typically takes 15-20 minutes and allows healthcare professionals to obtain an instant diagnosis so that they can more quickly begin treatment. in the israeli medical system, healthcare personnel prefer to perform rapid diagnostic tests since it eliminates the need for frequent visits and long queues. moreover, rapid influenza diagnostic tests provide the benefit of being more cost-effective compared to traditional methods such as reverse transcription-polymerase chain reaction (rt-pcr). rt-pcr typically requires the use of expensive materials and instruments, in addition to trained personnel. by offering the advantage of faster and more cost-effective testing, the demand for rapid influenza diagnostic tests is likely to remain strong in the coming years. the israeli government is also taking steps to improve access to rapid influenza diagnostic tests for the population. in 2017, the ministry of health launched a nationwide program to promote the use of rapid influenza diagnostic tests in primary care centers, emergency wards, and laboratories across the country. this program has been successful in increasing the uptake of rapid influenza diagnostic tests among healthcare professionals. therefore, it is expected that the demand for rapid influenza diagnostic tests in the israeli market will remain strong in the years to come. with the government initiatives to promote the use of these tests and the increased awareness among the population, the market is likely to register positive growth between 2018 and 2032.